Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study
Sophia J. Wagner(Brigham and Women's Hospital), Campbell S.D. Roxburgh(Glasgow Royal Infirmary), Piet A. van den Brandt(Netherlands Comprehensive Cancer Organisation), Claire Palles(University of Oxford), Nicholas J. Hawkins(UNSW Sydney), Rachel Kerr(Cancer Research UK Clinical Trials Unit), Tanwei Yuan(German Cancer Research Center), Wolfram Mueller(Praxis für Humangenetik), Gregory Patrick Veldhuizen(Fresenius (Germany)), Heike I. Grabsch(University of Leeds), Susan D. Richman(University of Leeds), Jitendra Jonnagaddala(UNSW Sydney), Daniel Reisenbüchler(Center for Environmental Health), Andrea Harkin(Queen's University Belfast), Jan Niehues(Durham University), Kelly Offermans(Maastricht University), Joseph D. Bonner(Michigan Medicine), Jiefu Zhu(Wuhan University), Nicholas P. West(Johannes Gutenberg University Mainz), Dion Morton(University of Birmingham), Gordon Hutchins(Leeds General Infirmary), Timothy Iveson(University Hospital Southampton NHS Foundation Trust), Caroline Kelly(Cancer Research UK), Philip Quirke(University of Leeds), Bengt Glimelius(Uppsala University), Michel Seymour(University of Leeds), Joanne Edwards(University of Glasgow), Jennifer Hay(Queen Elizabeth University Hospital), David N. Church(Centre for Human Genetics), Stephen B. Gruber(City Of Hope National Medical Center), Sebastian Foersch(Johannes Gutenberg University Mainz), Ismail Gögenür(University of Copenhagen), Robyn L. Ward(The University of Sydney), Laura Magill(St James's University Hospital), Josien C.A. Jenniskens(Maastricht University), Noori Maka(King's College London), Gad Rennert(Technion – Israel Institute of Technology), Enric Domingo(Universitätsklinikum Erlangen), Joel K. Greenson(University of Michigan), Rupert Langer(Johannes Kepler University of Linz), Clare Orange(University of Leeds), Richard Gray(Barnsley Hospital NHS Foundation Trust), Karin A. Oien(NHS Greater Glasgow and Clyde), Marta Nowak(University of Zurich), Jen Hay(Queen's University Belfast), Emma Jaeger(University of Oxford), Hannah Morgan(Glasgow Life), Daniel Schmolze(City Of Hope National Medical Center), Viktor H. Koelzer(University of Basel)
Cited by 246
Related Papers
Gastric cancer
|The Lancet|2020|4.8k
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
|New England Journal of Medicine|2008|2.3k
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
|The Lancet|2008|1.9k
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
|British Journal of Cancer|2020|1.7k